Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 8, 2003, Pages 799-804

  Miehlke, S ^a   Schneider Brachert, W ^b   Bastlein E ^c   Ebert, S ^a   Kirsch, C ^a   Haferland, C ^d   Buchner, M ^e   Neumeyer, M ^f   Vieth, M ^g   Stolte, M ^h   Lehn, N ^b   Bayerdorffer E ⁱ  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c Gastroenterologist in Priv Practice   (Germany)

^d Gastroenterologist in Priv Practice   (Germany)

^e Academic Teaching Hospital ^*  (Germany)

^f Gastroenterologist in Priv Practice   (Germany)

^g UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^h Academic Teaching Hospital   (Germany)

ⁱ UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DYSPEPSIA; ERADICATION THERAPY; ERYTHEMA; FEMALE; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OMEPRAZOLE; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 10744230068     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01764.x     Document Type: Article

References (23)

1. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis. Aliment Pharmacol Ther 1999; 13: 857-64.
2. Schmid CH, Whiting G, Cory D, Ross SD, Chalmers TC. Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials. Am J Ther 1999; 6: 25-36.
3. Miehlke S, Bayerdörffer E, Graham DY. Treatment of Helicobacter pylori infection. Sem Gastrointest Dis 2001; 12: 167-79.
4. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al The MACH 1 study: Optimal one-week treatment for H. pylori defined? Helicobacter 1996; 1: 138-44.
5. Lind T, Megraud F, Unge P, et al. The MACH 2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999; 116: 248-53.
6. Megraud F, Lehn N, Lind T, et al. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 1999; 43: 2747-52.
7. Malfertheiner P, Megraud F, O'Morain C, et al. The European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-80.
8. Wolle K, Leodolter A, Malfertheiner P, König W. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 2002; 51: 705-9.
9. Meyer JM, Silliman NP, Wang W, et al. Risk factors for Helicobacter pylori resistance in the United States: the Surveillance study of H. pylori Antimicrobial Resistance Partnership (SHARP) Study, 1993-99. Ann Intern Med 2001; 136: 13-24.
10. van der Wouden EJ, van Thijs JC, van Zwet AA, Sluiter WJ, Kleibeuker JH. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis. Am J Gastroenterol 1999; 94: 1751-9.
11. Dore MP, Leandro G, Realdi G, Sepulveda AR, Graham DY. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 2000; 45: 68-76.
12. Lind T, Rydberg L, Kyleback A, et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 861-7.
13. Röhss K, Wilder-Smith C, Claar-Nilsson C, Lundin C, Hasselgren G. Esomeprazole 40 mg provides more effective acid control than standard doses of all other proton pump inhibitors. Gastroenterology 2001; 120: A419 (Abstract).
14. Laine L, Fennerty MB, Osato M, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol 2000; 95: 3393-8.
15. Veldhuyzen van Zanten SJO, Lauritzen K, Delchier JC, et al. One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther 2000; 14: 1605-11.
16. Heep M, Kist M, Strobel S, Beck D, Lehn N. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis 2000; 19: 538-41.
17. Dixon MF, Genta RM, Yardley JH, et al Classification and grading of gastritis: the updated Sydney System. Am J Surg Pathol 1996; 20: 1161-81.
18. Breuer T, Graham DY. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective? Am J Gastroenterol 1999; 94: 725-9.
19. Toracchio S, Cellini L, Di Campli E, et al. Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14: 1639-43.
20. Veldhuyzen van Zanten SJO, Husein-Bhabha FA, Lee JSM. Effectiveness of either esomeprazole or omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori infection. Gut 2002; 51: A111 (Abstract).
21. Wang WH, Wong BC, Mukhopadhyay AK, et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment Pharmacol Ther 2000; 14: 901-10.
22. Miehlke S, Hansky K, Schneider-Brachert W, et al. Seven-day triple therapy with esomeprazole, rifabutin and amoxicillin is effective in eradicating Helicobacter pylori resistant to both metronidazole and clarithromycin - a prospective, randomized multicenter trial. Gastroenterology 2003; 124: A-359.
23. Miehlke S, Kirsch C, Schneider-Brachert W, et al. A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 2003; 8: 310-9.